Girard Partners Ltd. Pfizer Inc Transaction History

Girard Partners Ltd.

$1.06 Billion
Q2 2024

A detailed history of Girard Partners Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Girard Partners Ltd. holds 50,433 shares of PFE stock, worth $1.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

50,433

Previous 47,872 5.35%

Holding current value

$1.3 Million

Previous $1.33 Million 6.25%

% of portfolio

0.13%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $64,690 - $75,805	2,561 Added 5.35%	50,433 $1.41 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $112,492 - $129,176	-4,345 Reduced 8.32%	47,872 $1.33 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $200,887 - $260,930	-7,688 Reduced 12.83%	52,217 $1.5 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $4,235 - $4,951	-132 Reduced 0.22%	59,905 $1.99 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $25,175 - $29,127	697 Added 1.17%	60,037 $2.2 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $6,538 - $8,512	-166 Reduced 0.28%	59,340 $2.42 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $338,843 - $442,322	8,116 Added 15.79%	59,506 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $62,620 - $76,444	-1,431 Reduced 2.71%	51,390 $2.25 Million
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $42,249 - $50,094	908 Added 1.75%	52,821 $2.77 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $14,777 - $18,310	323 Added 0.63%	51,913 $2.69 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $28,345 - $42,017	-686 Reduced 1.31%	51,590 $3.05 Million
Q3 2021 Nov 01, 2021	BUY	$39.25 - $50.42 $1.96 Million - $2.52 Million	50,028 Added 2225.44%	52,276 $2.25 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $2.04 Million - $2.62 Million	-51,914 Reduced 95.85%	2,248 $2.25 Million
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $192,477 - $218,044	-5,360 Reduced 9.01%	54,162 $2.12 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $56,397 - $63,604	-1,684 Reduced 2.75%	59,522 $2.16 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $201,322 - $255,998	-6,015 Reduced 8.95%	61,206 $2.25 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $101,028 - $118,529	-3,182 Reduced 4.52%	67,221 $2.47 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $189,725 - $230,165	-6,299 Reduced 8.21%	70,403 $2.3 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $123,554 - $176,532	4,571 Added 6.34%	76,702 $2.5 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $31,537 - $35,790	958 Added 1.35%	72,131 $2.83 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $646,226 - $837,965	-19,890 Reduced 21.84%	71,173 $2.56 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $58,095 - $65,227	1,571 Added 1.76%	91,063 $3.94 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $50,437 - $55,414	1,345 Added 1.53%	89,492 $3.8 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $138,453 - $157,852	-3,599 Reduced 3.92%	88,147 $3.85 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $478,615 - $580,531	-13,885 Reduced 13.14%	91,746 $4.04 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $49,799 - $53,091	1,510 Added 1.45%	105,631 $3.83 Million
Q1 2018 Apr 18, 2018	BUY	$31.91 - $37.02 $33,026 - $38,315	1,035 Added 1.0%	104,121 $3.7 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $81,154 - $86,107	-2,440 Reduced 2.31%	103,086 $3.73 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $335,575 - $369,673	10,825 Added 11.43%	105,526 $3.77 Million
Q2 2017 Aug 08, 2017	BUY	N/A	94,701	94,701 $3.18 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Account

Girard Partners Ltd. Pfizer Inc Transaction History